Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108558927B details a novel Pd-catalyzed asymmetric alkenylation for silicon stereocenters. Discover cost-effective routes for high-purity pharmaceutical intermediates.
Patent CN113004181B reveals a novel Pd-catalyzed carbonylation method using sulfonyl chlorides, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN112480015B details a Pd-catalyzed one-pot synthesis. Offers cost reduction in API manufacturing and high-purity pharmaceutical intermediates with scalable protocols.
Patent CN108314642B reveals a green triethylamine-based route for 2-methylpyridines. Offers cost reduction and scalable pharma intermediate manufacturing without heavy metals.
Patent CN114539198B reveals a novel palladium-catalyzed route for chroman amides, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel NHC-catalyzed route for trifluoromethyl homoisoflavones offers mild conditions and high yields, ensuring reliable supply chain stability.
Patent CN116655529A reveals a nickel-catalyzed route for 3-aryl quinolines, offering mild conditions and high yields for reliable pharmaceutical intermediate supply chains.
Patent CN112125856A details a novel Pd-catalyzed carbonylation for 2-trifluoromethyl quinazolinones, offering safer synthesis and cost reduction in API manufacturing.
Patent CN113735826B reveals efficient palladium carbonylation for quinolone synthesis. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel Pd-catalyzed one-pot method for 2-CF3 quinazolinones. High yield, scalable process for API intermediates. Cost-effective supply chain solution.
Patent CN114539198B reveals novel Pd-catalyzed route enhancing supply chain stability and cost efficiency for high-purity pharmaceutical intermediates manufacturing globally.
Novel Pd-catalyzed carbonylation patent CN114751883B enables efficient benzofuran-3-carboxamide production. Reduces costs and improves supply chain reliability for pharmaceutical intermediates.
Patent CN114195711B reveals efficient Pd-catalyzed route. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN113735826B details a novel Pd-catalyzed carbonylation for 3-benzylidene-2,3-dihydroquinolone. Enhances supply chain reliability and reduces manufacturing complexity.
Novel Rh-catalyzed synthesis for high-purity trifluoromethyl benzo[1,8]naphthyridine. Cost-effective route for optoelectronic materials and pharmaceutical intermediates.
Novel Pd-catalyzed carbonylation method using benzyl formate. High purity aryl acetamides for pharma. Cost-effective and scalable process.
Patent CN118639250A reveals electrochemical succinic acid synthesis. Offers high yield and scalable green manufacturing for pharmaceutical intermediates.
Patent CN113105402B reveals a metal-free iodine-promoted synthesis for trifluoromethyl-triazoles, offering significant cost reduction in API manufacturing and scalable production.
Patent CN113105402B reveals a metal-free iodine-promoted route for trifluoromethylated triazoles, offering significant cost reduction in API manufacturing and scalable production.
Patent CN108484477B details a mild Rh-catalyzed route to 5-acyl benzo[a]carbazoles, offering cost reduction and scalable production for functional material manufacturing.